PARP1 and ovarian carcinoma: The poly(adenosine diphosphate ribose) polymerase (PARP) family of DNA end-binding core proteins is involved in one such DNA repair pathway [13], and inhibition of PARP1 (PARPi) has emerged as a promising therapeutic approach for the treatment of certain cancers, particularly breast and ovarian cancers.